Search
for
Sort by
Research 601–630 of 612
- Women Also Use 5α-Reductase Inhibitors
- Phytochemical characterization and therapeutic potential of major bioactive compounds from Hibiscus rosa-sinensis (gudhal) flowers: A comprehensive review
- Intermittent fasting triggers interorgan communication to suppress hair follicle regeneration
- Novel Biodegradable Polymeric Microparticles Facilitate Scarless Wound Healing by Promoting Re-epithelialization and Inhibiting Fibrosis
- Activation of Hair Cell Growth Factors by Linoleic Acid in Malva verticillata Seed
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Shedding Light on the Effects of Calorie Restriction and Its Mimetics on Skin Biology
- Early androgen activity after birth determines the hypothalamic expression of androgen and estrogen receptors in adulthood in female but not in male rats
- KeraGLO® Hydrolyzed Keratin: A Healthy Aging Supplement, Improved Skin and Hair in a Placebo Controlled Trial
- NEONATAL INHIBITION OF ANDROGEN ACTIVITY ALTERS THE PROGRAMMING OF BODY WEIGHT AND OREXINERGIC PEPTIDES DIFFERENTIALLY IN MALE AND FEMALE RATS
- Therapeutic Effects of Natural Products on Human Diseases
- Isoginkgetin, a natural biflavonoid from Ginkgo biloba, inhibits inflammatory response in endothelial cells via suppressing NF-κB activation
- Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study
- Cardiometabolic Risk Factors in Atorvastatin-Treated Women with Euthyroid Autoimmune Thyroiditis
- Cardiometabolic Risk Factors in Rosuvastatin-Treated Men with Mixed Dyslipidemia and Early-Onset Androgenic Alopecia
- Cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia
- Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Impact of lisinopril on cardiometabolic risk factors in men with hypertension and early-onset androgenetic alopecia
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Facial Appearance and Markers of Cardiometabolic Risk in Healthy Adult Men
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
- Nutrition and Emotional Health Education: The Use of Emotional Intelligence and a Plant-Based Diet to Reduce Cardiometabolic Risk
- Metabolic risk in PCOS: phenotype and adiposity impact
- Population-level risk of erectile dysfunction after finasteride use for androgenetic alopecia: a national cohort analysis
- A Multidisciplinary Lifestyle Intervention for Women with Polycystic Ovary Syndrome: The Role of a Pulse-Based Diet and Aerobic Exercise on Reproductive, Cardio-Metabolic, and Quality of Life Outcomes
- Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature
- Targets to treat androgen excess in polycystic ovary syndrome
- Polycystic ovary syndrome: pragmatic management across levels of care